NasdaqGS - Delayed Quote USD
Edgewise Therapeutics, Inc. (EWTX)
14.21
+0.19
+(1.36%)
At close: 4:00:01 PM EDT
14.30
+0.09
+(0.63%)
After hours: 5:18:29 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CARRUTHERS ROBERT MICHAEL Chief Financial Officer | Sale | May 2, 2025 | 81,014 |
| DERAKHSHAN BEHRAD Officer | Sale | May 2, 2025 | 20,355 |
| DONOVAN JOANNE M Officer | Sale | May 2, 2025 | 21,588 |
| FOX JONATHAN C Director | Stock Award(Grant) | Apr 1, 2025 | 11,416 |
| KOCH KEVIN Chief Executive Officer | Sale | May 2, 2025 | 385,813 |
| MOORE JOHN R General Counsel | Sale | May 2, 2025 | 6,531 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 3, 2025 | -- |
| RUSSELL ALAN J Officer and Director | Sale | May 2, 2025 | 18,521 |
| SEMIGRAN MARC Officer | Sale | Dec 24, 2024 | 6,716 |
| THOMPSON PETER A Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 3, 2025 | -- |
Related Tickers
DSGN Design Therapeutics, Inc.
3.8100
-1.55%
ERAS Erasca, Inc.
1.2200
+0.83%
CRNX Crinetics Pharmaceuticals, Inc.
29.76
-1.16%
CGEM Cullinan Therapeutics, Inc.
7.81
-1.01%
GLUE Monte Rosa Therapeutics, Inc.
3.9700
-1.98%
VRDN Viridian Therapeutics, Inc.
13.57
-0.73%
JANX Janux Therapeutics, Inc.
25.22
+0.04%
DAWN Day One Biopharmaceuticals, Inc.
6.27
0.00%
NUVL Nuvalent, Inc.
73.49
+0.36%
STOK Stoke Therapeutics, Inc.
9.36
-1.47%